NCT05352061Enrolling by invitation
Addressing Psychosocial Comorbidities in HIV Treatment and Prevention 2b
Addressing Psychosocial Comorbidities in HIV Treatment and Prevention: Phase 2b
Source: ClinicalTrials.gov · Last updated 26 Jun 2026
Brief summary (registry, in English)
The purpose of this study is to learn about ways to better support people living with HIV with their HIV treatment and cope with mental health challenges and/or substance use concerns.
- Status (registry)
- Enrolling by invitation
- Study type
- Interventional
- Enrollment
- 75 (estimated)
- First submitted
- 22 Apr 2022
- Start date
- 15 Aug 2022
- Primary completion date
- May 2027
- Lead sponsor
- University of Miami
- Diseases
- HIV
- NCT number
- NCT05352061
What you commit to
- Study type: Interventional
- Planned participants: 75
- From 15 Aug 2022 to the primary completion date, May 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Currently receiving CBT for a psychiatric disorder, or received a course of CBT in the past year.
Other illness
- Unable to provide informed consent due to severe mental or physical illness, cognitive impairment, or substance intoxication at the time of interview
- Active untreated, unstable, major mental illness (i.e., untreated psychosis or mania) that would interfere with study participation
Other
- Opinion of the PI that the participant would be at risk for harm to self or others
Who the study is looking for
- Age: 18 years or older
- HIV positive
- Evidence of uncontrolled virus (e.g., \> 20 copies/ml) within the past 12 months as verified by medical record
- Group 1: (Men who have sex with men (MSM) who have used stimulants within the past 4 months (approximately 10 participants))OR Group 2: transgender women (approximately 10 participants) OR Group 3: Emerging adults between the ages of 18 and 26 (inclusive; approximately 10 participants)
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Miami Coordinator of this site? Confirm its status | Miami | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.